VitaFlowTM II Transcatheter Aortic Valve System Study

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 178 participants.

Also called NCT03575039

  • Study
  • In this atlas

Overview

Design
Interventional study; allocation not applicable; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 178 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT03575039
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Not reported
Registry status
  • Unknown status (from the registry)

Technical summary

Registry record NCT03575039. Allocation not applicable; no masking; primary purpose treatment. Start 2018-08 (anticipated); primary completion 2020-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
VitaFlowTM II Transcatheter Aortic Valve System Study
Condition
Aortic Valve Stenosis
Intervention (Device)
VitaFlow II Transcatheter Aortic Valve System
Lead sponsor
Shanghai MicroPort CardioFlow Medtech Co., Ltd. (class: industry)

Record details

Record id
cardio:ct-nct03575039
Content hash
bbe0b61f8744d3235d67b03c27a6a2a7ef9fc128845e2d9d137ad8e93fa2098d